RI

RTW Investments Portfolio holdings

AUM $7.02B
This Quarter Return
+7.27%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$222M
AUM Growth
+$222M
Cap. Flow
-$55.2M
Cap. Flow %
-24.92%
Top 10 Hldgs %
90.89%
Holding
28
New
7
Increased
2
Reduced
7
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$58.5B
$37.1M 16.75% 355,395 +15,000 +4% +$1.57M
DYAX
2
DELISTED
DYAX CORPORATION
DYAX
$26.6M 11.99% 1,585,098 -546,710 -26% -$9.16M
DRNA
3
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$23.8M 10.75% 990,981 -125,000 -11% -$3M
KITE
4
DELISTED
Kite Pharma, Inc.
KITE
$21.7M 9.78% +375,623 New +$21.7M
BCRX icon
5
BioCryst Pharmaceuticals
BCRX
$1.74B
$20.4M 9.22% 2,261,361
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
$19.5M 8.79% 1,064,247
ARWR icon
7
Arrowhead Research
ARWR
$3.05B
$16.3M 7.36% 2,410,000 -200,000 -8% -$1.35M
ACHN
8
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$16M 7.22% 1,622,633
BLUE
9
DELISTED
bluebird bio
BLUE
$12.1M 5.45% +100,000 New +$12.1M
GYRE icon
10
Gyre Therapeutics
GYRE
$703M
$7.92M 3.57% 2,665,643
ZSPH
11
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$3M 1.35% 71,315 -303,506 -81% -$12.8M
ASMB icon
12
Assembly Biosciences
ASMB
$190M
$2.7M 1.22% 204,000
LENS
13
DELISTED
Presbia PLC Ordinary Shares
LENS
$2.59M 1.17% +350,000 New +$2.59M
ADVM icon
14
Adverum Biotechnologies
ADVM
$64.6M
$2.08M 0.94% 51,300 +1,300 +3% +$52.7K
RPRX
15
DELISTED
Repros Therapeutics Inc.
RPRX
$1.97M 0.89% 229,364
FBIO icon
16
Fortress Biotech
FBIO
$76.8M
$1.93M 0.87% +500,000 New +$1.93M
LPCN icon
17
Lipocine
LPCN
$15.8M
$1.44M 0.65% 209,333
TARO
18
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$1.23M 0.56% 8,721 -259,162 -97% -$36.6M
RLYP
19
DELISTED
RELYPSA INC COM
RLYP
$1.15M 0.52% 31,872 -418,367 -93% -$15.1M
APEN
20
DELISTED
Apollo Endosurgery, Inc.
APEN
$148K 0.07% 60,000
SHAK icon
21
Shake Shack
SHAK
$4.27B
$25K 0.01% +500 New +$25K
TENX icon
22
Tenax Therapeutics
TENX
$27.3M
$8K ﹤0.01% +2,400 New +$8K
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.09T
$7K ﹤0.01% +50 New +$7K
PLX icon
24
Protalix BioTherapeutics
PLX
$124M
-843,851 Closed -$1.55M
VNDA icon
25
Vanda Pharmaceuticals
VNDA
$279M
-500,000 Closed -$7.16M